Generic placeholder image

Current Molecular Medicine


ISSN (Print): 1566-5240
ISSN (Online): 1875-5666

Research Article

Dexmedetomidine Attenuates Spinal Cord Ischemia-reperfusion Injury in Rabbits by Decreasing Oxidation and Apoptosis

Author(s): Bingbing Liu, Yatong Liang, Weihua Huang, Hui Zhang, Daiwei Zhou* and Xiaoshan Xiao*

Volume 23, Issue 6, 2023

Published on: 15 August, 2022

Page: [569 - 577] Pages: 9

DOI: 10.2174/1566524022666220525142954

Price: $65


Background: In brain ischemia, dexmedetomidine (DEX) prevents glutamate and norepinephrine changes, increases nerve conduction, and prevents apoptosis, but the mechanisms are poorly understood.

Objective: This study aimed at examining the protective effect and function of DEX on spinal cord ischemia-reperfusion injury (SCIRI) and whether the effect is mediated by oxidative stress and apoptosis (with the involvement of Bcl-2, Bax, mitochondria, and Caspase-3).

Methods: Rabbits were randomly divided into the sham group, infusion/reperfusion (I/R) group, and DEX+I/R group. SCIRI was induced by occluding the aorta just caudal to the left renal artery for 40 min, followed by reperfusion. DEX was continuously administered for 60 min before clamping. The animals were evaluated for neuronal functions. Spinal cord tissues were examined for SOD activity and MDA content. Bcl-2, Bax, and Caspase-3 expressions were detected by western blotting. TUNEL staining was used for apoptosis.

Results: With the extension of reperfusion time, the hind limbs’ neurological function in the DEX+I/R group gradually improved, but it became worse in the I/R group (all P<0.05 vs. the other time points within the same groups). Compared with I/R, DEX decreased MDA and increased SOD (P<0.01), upregulated Bcl-2 protein expression (P<0.05), downregulated Bax expression (P<0.05), decreased caspase-3 expression (P<0.05), prevented histological changes in neurons, and decreased the apoptotic index of the TUNEL labeling (P<0.05).

Conclusion: DEX could attenuate SCIRI in rabbits by improving the oxidative stress status, regulating the expression of apoptosis-related proteins, and decreasing neuronal apoptosis.

Keywords: Spinal cord injury, ischemia-reperfusion injury, dexmedetomidine, apoptosis, Bcl-2, oxidative stress.

Conrad MF, Ye JY, Chung TK, Davison JK, Cambria RP. Spinal cord complications after thoracic aortic surgery: Long-term survival and functional status varies with deficit severity. J Vasc Surg 2008; 48(1): 47-53.
[] [PMID: 18486422]
Zhou L, Zuo Z, Chow MS. Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 2005; 45(12): 1345-59.
[] [PMID: 16291709]
Yang B, Harris KP, Jain S, Nicholson ML. Caspase-7, Fas and FasL in long-term renal ischaemia/reperfusion and immunosuppressive injuries in rats. Am J Nephrol 2007; 27(4): 397-408.
[] [PMID: 17596683]
Zhang F, Ding T, Yu L, Zhong Y, Dai H, Yan M. Dexmedetomidine protects against oxygen-glucose deprivation-induced injury through the I2 imidazoline receptor-PI3K/AKT pathway in rat C6 glioma cells. J Pharm Pharmacol 2012; 64(1): 120-7.
[] [PMID: 22150679]
Broughton BR, Reutens DC, Sobey CG. Apoptotic mechanisms after cerebral ischemia. Stroke 2009; 40(5): e331-9.
[] [PMID: 19182083]
Engelhard K, Werner C, Eberspacher E, Bachl M, Blobner M, Hildt E, et al. The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg 2003; 96(2): 524-31.
Ma D, Hossain M, Rajakumaraswamy N, et al. Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. Eur J Pharmacol 2004; 502(1-2): 87-97.
[] [PMID: 15464093]
Can M, Gul S, Bektas S, Hanci V, Acikgoz S. Effects of dexmedetomidine or methylprednisolone on inflammatory responses in spinal cord injury. Acta Anaesthesiol Scand 2009; 53(8): 1068-72.
[] [PMID: 19519725]
García-Sánchez A, Miranda-Díaz AG, Cardona-Muñoz EG. The role of oxidative stress in physiopathology and pharmacological treatment with pro- and antioxidant properties in chronic diseases. Oxid Med Cell Longev 2020; 2020: 2082145.
[] [PMID: 32774665]
Sies H. Oxidative Stress: Concept and some practical aspects. Antioxidants 2020; 9(9): E852.
[] [PMID: 32927924]
Seyhan N, Canseven AG. In vivo effects of ELF MFs on collagen synthesis, free radical processes, natural antioxidant system, respiratory burst system, immune system activities, and electrolytes in the skin, plasma, spleen, lung, kidney, and brain tissues. Electromagn Biol Med 2006; 25(4): 291-305.
[] [PMID: 17178588]
Sarada S, Himadri P, Mishra C, Geetali P, Ram MS, Ilavazhagan G. Role of oxidative stress and NFkB in hypoxia-induced pulmonary edema. Exp Biol Med 2008; 233(9): 1088-98.
[] [PMID: 18641050]
Redza-Dutordoir M, Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta 2016; 1863(12): 2977-92.
[] [PMID: 27646922]
Gul S, Hanci V, Bahadir B, et al. The effectiveness of dexmedetomidine in experimental spinal cord injury compared to methylprednisolone in rats. J Clin Neurosci 2010; 17(4): 490-4.
[] [PMID: 20116256]
Gu J, Chen J, Xia P, Tao G, Zhao H, Ma D. Dexmedetomidine attenuates remote lung injury induced by renal ischemia-reperfusion in mice. Acta Anaesthesiol Scand 2011; 55(10): 1272-8.
[] [PMID: 22092133]
Gu J, Sun P, Zhao H, et al. Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit Care 2011; 15(3): R153.
[] [PMID: 21702944]
Yang CL, Chen CH, Tsai PS, Wang TY, Huang CJ. Protective effects of dexmedetomidine-ketamine combination against ventilator-induced lung injury in endotoxemia rats. J Surg Res 2011; 167(2): e273-81.
[] [PMID: 20452617]
Okada H, Kurita T, Mochizuki T, Morita K, Sato S. The cardioprotective effect of dexmedetomidine on global ischaemia in isolated rat hearts. Resuscitation 2007; 74(3): 538-45.
[] [PMID: 17391832]
Kalkan E, Eser O, Avunduk MC, Coşar M, Fidan H, Kalkan S. Apoptosis and cerebral ischemic reperfusion injury developed after haemorrhagic shock: Experimental study. Ulus Travma Acil Cerrahi Derg 2006; 12(4): 263-7.
[PMID: 17029115]
Eser O, Fidan H, Sahin O, et al. The influence of dexmedetomidine on ischemic rat hippocampus. Brain Res 2008; 1218: 250-6.
[] [PMID: 18514174]
Sanders RD, Xu J, Shu Y, et al. Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. Anesthesiology 2009; 110(5): 1077-85.
[] [PMID: 19352168]
Goyagi T, Nishikawa T, Tobe Y, Masaki Y. The combined neuroprotective effects of lidocaine and dexmedetomidine after transient forebrain ischemia in rats. Acta Anaesthesiol Scand 2009; 53(9): 1176-83.
[] [PMID: 19388884]
Sanders RD, Sun P, Patel S, Li M, Maze M, Ma D. Dexmedetomidine provides cortical neuroprotection: Impact on anaesthetic-induced neuroapoptosis in the rat developing brain. Acta Anaesthesiol Scand 2010; 54(6): 710-6.
[] [PMID: 20003127]
Zhou D, Liu B, Xiao X, Dai P, Ma S, Huang W. The effect of safflower yellow on spinal cord ischemia reperfusion injury in rabbits. Oxid Med Cell Longev 2013; 2013: 692302.
[] [PMID: 24381717]
Yao W, Luo G, Zhu G, et al. Propofol activation of the Nrf2 pathway is associated with amelioration of acute lung injury in a rat liver transplantation model. Oxid Med Cell Longev 2014; 2014: 258567.
[] [PMID: 24669282]
Levine B, Sinha SC, Kroemer G. Bcl-2 family members: Dual regulators of apoptosis and autophagy. Autophagy 2008; 4(5): 600-6.
[] [PMID: 28186856]
Tsujimoto Y. Role of Bcl-2 family proteins in apoptosis: Apoptosomes or mitochondria? Genes Cells 1998; 3(11): 697-707.
[] [PMID: 9990505]
Antonsson B, Martinou JC. The Bcl-2 protein family. Exp Cell Res 2000; 256(1): 50-7.
[] [PMID: 10739651]
Wang Y, Liu X, Zhang D, Chen J, Liu S, Berk M. The effects of apoptosis vulnerability markers on the myocardium in depression after myocardial infarction. BMC Med 2013; 11(1): 32.
[] [PMID: 23394076]
Thornberry NA, Lazebnik Y. Caspases: Enemies within. Science 1998; 281(5381): 1312-6.
[] [PMID: 9721091]
Kakinohana M, Kida K, Minamishima S, et al. Delayed paraplegia after spinal cord ischemic injury requires caspase-3 activation in mice. Stroke 2011; 42(8): 2302-7.
[] [PMID: 21700940]
Panzer O, Moitra V, Sladen RN. Pharmacology of sedative-analgesic agents: Dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripheral mu antagonists. Crit Care Clin 2009; 25(3): 451-69.
Yilmaz ER, Kertmen H, Dolgun H, et al. Effects of darbepoetin-α in spinal cord ischemia-reperfusion injury in the rabbit. Acta Neurochir (Wien) 2012; 154(6): 1037-43.
[] [PMID: 22354718]
Diaz-Ruiz A, Rios C, Duarte I, et al. Lipid peroxidation inhibition in spinal cord injury: Cyclosporin-A vs methylprednisolone. Neuroreport 2000; 11(8): 1765-7.
[] [PMID: 10852240]
Zhang XY, Liu ZM, Wen SH, et al. Dexmedetomidine administration before, but not after, ischemia attenuates intestinal injury induced by intestinal ischemia-reperfusion in rats. Anesthesiology 2012; 116(5): 1035-46.
[] [PMID: 22417965]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy